Drugs / 5% glucose
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07825155 | Mar → Jun 2026 overdue | carpal tunnel syndrome | Tanta University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 5% glucose | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07825155 ↗ |
| Known as | D5W | “Participants in the 5% glucose group will receive 5 mL of 5% glucose (D5W) by ultrasound-guided hydrodissection around the median nerve.” NCT07825155 ↗ |
| Route | Other | “by ultrasound-guided hydrodissection around the median nerve” NCT07825155 ↗ |